CN106589693A - Medical antibacterial polymer material - Google Patents

Medical antibacterial polymer material Download PDF

Info

Publication number
CN106589693A
CN106589693A CN201611145774.9A CN201611145774A CN106589693A CN 106589693 A CN106589693 A CN 106589693A CN 201611145774 A CN201611145774 A CN 201611145774A CN 106589693 A CN106589693 A CN 106589693A
Authority
CN
China
Prior art keywords
parts
medical antibacterial
macromolecular material
rare earth
copper oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611145774.9A
Other languages
Chinese (zh)
Inventor
马鸿志
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuxi Sifang Macromolecule Material Co Ltd
Original Assignee
Wuxi Sifang Macromolecule Material Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuxi Sifang Macromolecule Material Co Ltd filed Critical Wuxi Sifang Macromolecule Material Co Ltd
Priority to CN201611145774.9A priority Critical patent/CN106589693A/en
Publication of CN106589693A publication Critical patent/CN106589693A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L27/00Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Compositions of derivatives of such polymers
    • C08L27/02Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L27/04Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Compositions of derivatives of such polymers not modified by chemical after-treatment containing chlorine atoms
    • C08L27/06Homopolymers or copolymers of vinyl chloride
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00Applications
    • C08L2203/02Applications for biomedical use

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention discloses a medical antibacterial polymer material. The material is prepared from, by weight, 65-70 parts of polyvinyl chloride resin, 2-4 parts of XF, 1-3 parts of green long afterglow phosphor powder of rare earth, 1-3 copper oxide, 2-3 parts of TAME, 2-3 parts of yttrium nitrate catalyst, 4-10 parts of dioctyl sebacate, 2-4 parts of PPB, 2-5 parts of rice bran wax, 2-4 parts of halloysite nanotube, 5-8 parts of ammonium hydroxide of 30%, 1-3 parts of sodium myrastate and 1-3 parts of quicklime. By the method, the medical antibacterial polymer material has good antibacterial performance, and prevents medicine or equipment from being polluted by bacteria.

Description

Medical antibacterial macromolecular material
Technical field
The present invention relates to technical field of macromolecules, more particularly to a kind of medical antibacterial macromolecular material.
Background technology
Modern industrial society develops rapidly, and the utilization of macromolecular material is more and more extensive, and Ge great colleges and universities, research institution etc. are all It is provided with macromolecular material research center.Macromolecular material is also referred to as polymeric material, be based on macromolecular compound, then It is furnished with other additives(Auxiliary agent)The material for being constituted, macromolecular material are divided into rubber, fiber, plastics, macromolecule glue by characteristic Stick, high-molecular coating and polymer-based composite etc..Macromolecular material electric and electronic industry, aerospace industry, building industry, All it is widely used in all trades and professions such as medical apparatus and instruments, medical packaging, transportation, household electrical appliance, agricultural.In medicine bag Macromolecular material is widely used in dress industry, at present, the anti-microbial property of this macromolecular material is not good.
The content of the invention
The invention mainly solves the technical problem of a kind of medical antibacterial macromolecular material is provided, with preferable antibiotic property Can, it is to avoid medicine or apparatus are contaminated by bacterial.
To solve above-mentioned technical problem, one aspect of the present invention is:A kind of medical antibacterial macromolecule is provided Material, including the component of following weight portion:The rare earth luminous powder of 65 ~ 70 parts of Corvic, XF2 ~ 4 part, green long afterglow 1 ~ 3 Part, 1 ~ 3 part of copper oxide, TAME2 ~ 3 part, 2 ~ 3 parts of Yttrium trinitrate catalyst, 4 ~ 10 parts of SA dibutyl ester, PPB2 ~ 4 part, rice bran wax 1 ~ 3 part of 2 ~ 5 parts, 2 ~ 4 parts of halloysite nanotubes, 30% 5 ~ 8 parts of ammonia, 1 ~ 3 part of myristic acid soda soap and quick lime.
In a preferred embodiment of the present invention, including the component of following weight portion:65 parts of Corvic, XF2 parts, 1 part of the rare earth luminous powder of green long afterglow, 1 part of copper oxide, TAME2 parts, 2 parts of Yttrium trinitrate catalyst, 4 parts of SA dibutyl ester, 1 part of PPB2 parts, 2 parts of rice bran wax, 2 parts of halloysite nanotubes, 30% 5 parts of ammonia, 1 part of myristic acid soda soap and quick lime.
In a preferred embodiment of the present invention, including the component of following weight portion:68 parts of Corvic, XF3 parts, green 2 parts of long afterglow rare earth phosphor, 2 parts of copper oxide, TAME2.6 parts, 2.1 parts of Yttrium trinitrate catalyst, 8 parts of SA dibutyl ester, 2 parts of PPB3 parts, 3 parts of rice bran wax, 3 parts of halloysite nanotubes, 30% 6 parts of ammonia, 2 parts of myristic acid soda soap and quick lime.
In a preferred embodiment of the present invention, including the component of following weight portion:70 parts of Corvic, XF4 parts, 3 parts of the rare earth luminous powder of green long afterglow, 3 parts of copper oxide, TAME3 parts, 3 parts of Yttrium trinitrate catalyst, 10 parts of SA dibutyl ester, 3 parts of PPB4 parts, 5 parts of rice bran wax, 4 parts of halloysite nanotubes, 30% 8 parts of ammonia, 3 parts of myristic acid soda soap and quick lime.
The invention has the beneficial effects as follows:Medical antibacterial macromolecular material of the present invention, with preferable anti-microbial property, it is to avoid doctor Medicine or apparatus are contaminated by bacterial.
Specific embodiment
Technical scheme in the embodiment of the present invention will be clearly and completely described below, it is clear that described enforcement Example is only a part of embodiment of the present invention, rather than the embodiment of whole.Based on the embodiment in the present invention, this area is common All other embodiment that technical staff is obtained under the premise of creative work is not made, belongs to the model of present invention protection Enclose.
The embodiment of the present invention includes:
Embodiment one:
A kind of medical antibacterial macromolecular material, including the component of following weight portion:65 parts of Corvic, XF2 parts, green are long 1 part of the rare earth luminous powder of twilight sunset, 1 part of copper oxide, TAME2 parts, 2 parts of Yttrium trinitrate catalyst, 4 parts of SA dibutyl ester, PPB2 parts, rice 1 part of 2 parts of bran wax, 2 parts of halloysite nanotubes, 30% 5 parts of ammonia, 1 part of myristic acid soda soap and quick lime.
Embodiment two:
A kind of medical antibacterial macromolecular material, including the component of following weight portion:68 parts of Corvic, XF3 parts, green are long 2 parts of the rare earth luminous powder of twilight sunset, 2 parts of copper oxide, TAME2.6 parts, 2.1 parts of Yttrium trinitrate catalyst, 8 parts of SA dibutyl ester, PPB3 2 parts of part, 3 parts of rice bran wax, 3 parts of halloysite nanotubes, 30% 6 parts of ammonia, 2 parts of myristic acid soda soap and quick lime.
Embodiment three:
A kind of medical antibacterial macromolecular material, including the component of following weight portion:70 parts of Corvic, XF4 parts, green are long 3 parts of the rare earth luminous powder of twilight sunset, 3 parts of copper oxide, TAME3 parts, 3 parts of Yttrium trinitrate catalyst, 10 parts of SA dibutyl ester, PPB4 parts, 3 parts of 5 parts of rice bran wax, 4 parts of halloysite nanotubes, 30% 8 parts of ammonia, 3 parts of myristic acid soda soap and quick lime.
The invention has the beneficial effects as follows:Medical antibacterial macromolecular material of the present invention, with preferable anti-microbial property, it is to avoid doctor Medicine or apparatus are contaminated by bacterial.
Embodiments of the invention are the foregoing is only, the scope of the claims of the present invention is not thereby limited, it is every using this Equivalent structure or equivalent flow conversion that bright description is made, or directly or indirectly it is used in other related technology necks Domain, is included within the scope of the present invention.

Claims (4)

1. a kind of medical antibacterial macromolecular material, it is characterised in that including the component of following weight portion:Corvic 65 ~ 70 parts, XF2 ~ 4 part, 1 ~ 3 part of the rare earth luminous powder of green long afterglow, 1 ~ 3 part of copper oxide, TAME2 ~ 3 part, Yttrium trinitrate catalyst 2 ~ 3 Part, 4 ~ 10 parts of SA dibutyl ester, PPB2 ~ 4 part, 2 ~ 5 parts of rice bran wax, 2 ~ 4 parts of halloysite nanotubes, 30% 5 ~ 8 parts of ammonia, 1 ~ 3 part of 1 ~ 3 part of myristic acid soda soap and quick lime.
2. medical antibacterial macromolecular material according to claim 1, it is characterised in that including the component of following weight portion: 65 parts of Corvic, XF2 parts, 1 part of the rare earth luminous powder of green long afterglow, 1 part of copper oxide, TAME2 parts, Yttrium trinitrate catalyst 2 parts, 4 parts of SA dibutyl ester, PPB2 parts, 2 parts of rice bran wax, 2 parts of halloysite nanotubes, 30% 5 parts of ammonia, Sodium myristate 1 part of 1 part of soap and quick lime.
3. medical antibacterial macromolecular material according to claim 1, it is characterised in that including the component of following weight portion: 68 parts of Corvic, XF3 parts, 2 parts of the rare earth luminous powder of green long afterglow, 2 parts of copper oxide, TAME2.6 parts, Yttrium trinitrate catalysis 2.1 parts of agent, 8 parts of SA dibutyl ester, PPB3 parts, 3 parts of rice bran wax, 3 parts of halloysite nanotubes, 30% 6 parts of ammonia, Semen Myristicae 2 parts of 2 parts of sour soda soap and quick lime.
4. medical antibacterial macromolecular material according to claim 1, it is characterised in that including the component of following weight portion: 70 parts of Corvic, XF4 parts, 3 parts of the rare earth luminous powder of green long afterglow, 3 parts of copper oxide, TAME3 parts, Yttrium trinitrate catalyst 3 parts, 10 parts of SA dibutyl ester, PPB4 parts, 5 parts of rice bran wax, 4 parts of halloysite nanotubes, 30% 8 parts of ammonia, Sodium myristate 3 parts of 3 parts of soap and quick lime.
CN201611145774.9A 2016-12-13 2016-12-13 Medical antibacterial polymer material Pending CN106589693A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611145774.9A CN106589693A (en) 2016-12-13 2016-12-13 Medical antibacterial polymer material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611145774.9A CN106589693A (en) 2016-12-13 2016-12-13 Medical antibacterial polymer material

Publications (1)

Publication Number Publication Date
CN106589693A true CN106589693A (en) 2017-04-26

Family

ID=58802088

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611145774.9A Pending CN106589693A (en) 2016-12-13 2016-12-13 Medical antibacterial polymer material

Country Status (1)

Country Link
CN (1) CN106589693A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107841063A (en) * 2017-11-14 2018-03-27 安徽省健源医疗器械设备有限公司 A kind of antibacterial acid and alkali-resistance medical use high polymer material

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104403229A (en) * 2014-11-24 2015-03-11 苏州市贝克生物科技有限公司 Medical antibacterial PVC(polyvinyl chloride) film and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104403229A (en) * 2014-11-24 2015-03-11 苏州市贝克生物科技有限公司 Medical antibacterial PVC(polyvinyl chloride) film and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
汪多仁主编: "《增塑剂化学品生产配方和合成工艺》", 31 August 1999 *
陈昌杰主编: "《塑料功能性包装薄膜》", 28 February 2010 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107841063A (en) * 2017-11-14 2018-03-27 安徽省健源医疗器械设备有限公司 A kind of antibacterial acid and alkali-resistance medical use high polymer material

Similar Documents

Publication Publication Date Title
CN101333788B (en) Functional wallpaper material capable of purifying air
CN104263198A (en) Nanocomposite road marking coating material
CN104327787B (en) A kind of carton processing adhesive
CN105820433B (en) A kind of polypropylene edge band and preparation method
CN106589693A (en) Medical antibacterial polymer material
CN105062314A (en) High-low-temperature resistant UV plastic coating and preparation method thereof
CN203697606U (en) Anti-pollution drug packaging composite membrane
CN107868617A (en) A kind of anti-mildew dry powder paint of Multi-purpose antibiotic
CN105885321B (en) A kind of polyolefin/vinylpyridine system shape memory elastic body and preparation method thereof
CN108276885A (en) A kind of environmentally protective antibiotic paint and preparation method thereof
CN106633800A (en) Environment-friendly high-molecular material
CN106633609A (en) Abrasion-resistant plastic gear
CN113549352A (en) Preparation method of high-activity graphene-based composite antiviral water-based diatom coating
CN103333475A (en) Bactericidal polycarbonate fluorescent thin film
CN106633799A (en) Degradable high polymer material
CN106751722A (en) High resiliency macromolecular material
CN106589692A (en) Novel antibacterial high polymer material
CN106633614A (en) Abrasion-resistant high-molecular plastic gear
CN104341871A (en) Antibacterial environment-friendly paint
CN106674985A (en) Novel degradable high molecular material
CN106832847A (en) High molecule plastic blade
CN106633517A (en) Medical high-polymer material
CN106378966A (en) Sludge recycling method
CN103849190A (en) Bactericidal coating, and preparation method and applications thereof
CN106582508A (en) Mineral drying agent

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170426

WD01 Invention patent application deemed withdrawn after publication